Csaba Szántai-Kis Selected Research

Csaba Szántai-Kis Research Topics

3	Neoplasms (Cancer) 09/2019 - 06/2009
2	Carcinoma (Carcinomatosis) 10/2016 - 06/2009
2	Inflammation (Inflammations) 01/2015 - 01/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Leukemia 01/2018
1	Melanoma (Melanoma, Malignant) 01/2016
1	Obesity 01/2016
1	Insulin Resistance 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Pathologic Neovascularization 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2014
1	Epilepsy (Aura) 03/2011
1	Seizures (Absence Seizure) 03/2011
1	Colorectal Neoplasms (Colorectal Cancer) 06/2009

7	Phosphotransferases (Kinase)IBA 12/2019 - 06/2009
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 04/2014
2	Protein Kinases (Protein Kinase)IBA 01/2015 - 01/2015
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2015 - 01/2015
2	Protein Kinase InhibitorsIBA 03/2011 - 06/2009
1	tyrosine receptor (receptor, tyrosine)IBA 12/2019
1	EstersIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 10/2016
1	Tyrosine (L-Tyrosine)FDA Link 10/2016
1	pyridineIBA 01/2016
1	PyrazinesIBA 01/2016
1	Nonesterified Fatty Acids (NEFA)IBA 01/2016
1	Insulin Receptor Substrate ProteinsIBA 01/2016
1	Serine (L-Serine)FDA Link 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016

2	Therapeutics 09/2019 - 01/2016